Literature DB >> 11533220

Characterization of envelope glycoprotein mutants for human T-cell leukemia virus type 1 infectivity and immortalization.

T Tsukahara1, M M Wielgosz, L Ratner.   

Abstract

The human T-cell leukemia virus type 1 (HTLV-1) envelope protein is required for virus spread. This study further characterizes the role of the envelope protein in HTLV-1 immortalization. Viruses with single amino acid substitutions within the SU protein at residue 75, 81, 95, 101, 105, or 195 or with a C-terminal cytoplasmic domain truncation (CT), as well as an envelope-null (EN) virus, were generated within an infectious molecular clone, ACH. Transfection of 293T cells resulted in the release of similar amounts of virus particles from all of the mutants as determined by p19 enzyme-linked immunosorbent assay and immunoblot analysis of Gag in cell lysates and supernatants. The virus particles from all mutants except ACH-101, ACH-CT, and ACH-EN were infectious for B5 macaque cells in cell-free and cell-to-cell transmission assays and were capable of immortalizing transfected CD4(+) lymphocytes. These results indicate that HTLV-1 spread is required for immortalization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533220      PMCID: PMC114525          DOI: 10.1128/JVI.75.19.9553-9559.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Immortalization of T lymphocytes by human T-cell leukemia virus type 1 is independent of the tax-CBP/p300 interaction.

Authors:  M D Robek; L Ratner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  The HTLV receptor is a widely expressed protein.

Authors:  S R Trejo; L Ratner
Journal:  Virology       Date:  2000-03-01       Impact factor: 3.616

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; T Akagi; Y Ohtsuki; Y Shiraishi; K Nagata; Y Hinuma
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

5.  Direct transformation of rodent fibroblasts by jaagsiekte sheep retrovirus DNA.

Authors:  N Maeda; M Palmarini; C Murgia; H Fan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

6.  The Y-S-L-I tyrosine-based motif in the cytoplasmic domain of the human T-cell leukemia virus type 1 envelope is essential for cell-to-cell transmission.

Authors:  L Delamarre; C Pique; A R Rosenberg; V Blot; M P Grange; I Le Blanc; M C Dokhélar
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

7.  Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line.

Authors:  N Yamamoto; M Okada; Y Koyanagi; M Kannagi; Y Hinuma
Journal:  Science       Date:  1982-08-20       Impact factor: 47.728

8.  Isolation and transmission of human retrovirus (human t-cell leukemia virus).

Authors:  M Popovic; P S Sarin; M Robert-Gurroff; V S Kalyanaraman; D Mann; J Minowada; R C Gallo
Journal:  Science       Date:  1983-02-18       Impact factor: 47.728

9.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  9 in total

1.  Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.

Authors:  David Ghez; Yves Lepelletier; Sophie Lambert; Jean-Marie Fourneau; Vincent Blot; Sébastien Janvier; Bertrand Arnulf; Peter M van Endert; Nikolaus Heveker; Claudine Pique; Olivier Hermine
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations.

Authors:  Lee R Silverman; Andrew J Phipps; Andy Montgomery; Soledad Fernandez; Tomonori Tsukahara; Lee Ratner; Michael D Lairmore
Journal:  Blood       Date:  2005-07-26       Impact factor: 22.113

3.  Cholesterol dependence of HTLV-I infection.

Authors:  Matthew M Wielgosz; Daniel A Rauch; Kathryn S Jones; Frank W Ruscetti; Lee Ratner
Journal:  AIDS Res Hum Retroviruses       Date:  2005-01       Impact factor: 2.205

4.  Substitution of HIV Type 1 Nef with HTLV-1 p12.

Authors:  Tomonori Tsukahara; Lee Ratner
Journal:  AIDS Res Hum Retroviruses       Date:  2004-09       Impact factor: 2.205

Review 5.  Pathogenesis and treatment of human T-cell leukemia virus infection.

Authors:  Lee Ratner
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

6.  Human T-cell leukemia virus type 1 blunts signaling by interferon alpha.

Authors:  Xuan Feng; Lee Ratner
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

7.  Suppression of human T-cell leukemia virus I gene expression by pokeweed antiviral protein.

Authors:  Sheila Mansouri; Gunjan Choudhary; Paulina M Sarzala; Lee Ratner; Katalin A Hudak
Journal:  J Biol Chem       Date:  2009-09-11       Impact factor: 5.157

8.  Human T lymphotropic virus type 1 SU residue 195 plays a role in determining the preferential CD4+ T cell immortalization/transformation tropism.

Authors:  Priya Kannian; Soledad Fernandez; Kathryn S Jones; Patrick L Green
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

Review 9.  Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.

Authors:  Michael D Lairmore; Rajaneesh Anupam; Nadine Bowden; Robyn Haines; Rashade A H Haynes; Lee Ratner; Patrick L Green
Journal:  Viruses       Date:  2011-07-12       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.